Global Antibody Production Market Set to Cross $28 Billion by 2026 - Growing Demand for Protein Therapeutics & Rising Adoption of Targeted Immunotherapy - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 21, 2019--
The “Global Antibody Production Market Analysis 2019” report has been added to ResearchAndMarkets.com’s offering.
The Antibody Production market is expected to reach $28.11 billion by 2026 growing at a CAGR of 14.2% from 2018 to 2026.
Factors such as an increase in the adoption of targeted immunotherapy improved approval rate of therapeutic antibodies by regulatory authorities, and the rise in R&D expenditure of pharmaceutical and biotechnology companies are driving the market growth. Though, the high cost of primary antibodies restrains the market growth. Moreover, the growing demand for protein therapeutics and growth in adoption of targeted immunotherapy are providing ample growth opportunities for the antibody production market.
Based on the end-user, the pharmaceutical and biotechnology companies segment is going to have a lucrative growth during the forecast period, owing to the large production of therapeutic antibodies and high investment in R&D by companies for drug development.
Key Questions Answered in this Report
Key Topics Covered
1 Market Synopsis
2 Research Outline
3 Market Dynamics
4 Market Environment
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Antibody Production Market, By Process
5.2 Multimodal Chromatography Resins
5.3 Ion Exchange (IEX) Chromatography Resins
5.5 Hydrophobic Interaction Chromatography (HIC) Resins
5.6 Upstream Processing
5.7 Downstream Processing
6 Global Antibody Production Market, By Type
6.2 Monoclonal Antibody
6.3 Polyclonal Antibody
6.4 Other Antibody Types
7 Global Antibody Production Market, By Device
8 Global Antibody Production Market, By Dynamics
8.7 Other Animals
9 Global Antibody Production Market, By Application
10 Global Antibody Production Market, By End User
10.2 Diagnostic Laboratories
10.3 Research & Academic Institutes
10.4 Pharmaceutical and Biotechnology Companies
10.5 Other End Users
11 Global Antibody Production Market, By Geography
11.1 North America
11.4 South America
11.5 Middle East & Africa
12 Strategic Benchmarking
13 Vendors Landscape
13.1 Thermo Fisher Scientific, Inc.
13.2 F. Hoffmann-La Roche Ltd.
13.3 Merck KGaA
13.4 Abbott Laboratories
13.5 Pall Corporation
13.6 GE Healthcare
13.7 Bio-Rad Laboratories Inc.
13.8 Danaher Corporation
13.9 Sartorius AG
13.10 Cellab GmbH
13.11 Fibercell Systems Inc.
13.12 GeneTex Inc.
13.13 Sigma Aldrich Corporation
13.14 INTEGRA Biosciences AG
13.15 Abcam plc
13.16 Enzo Life Sciences Inc.
13.17 Novus Biologicals
For more information about this report visit https://www.researchandmarkets.com/r/9hdzrt
View source version on businesswire.com:https://www.businesswire.com/news/home/20191121005641/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 11/21/2019 10:06 AM/DISC: 11/21/2019 10:06 AM